DR REDDYS LABORATORIES LTD (RDY) — Earnings Call Analysis & IR Page

DR REDDYS LABORATORIES LTD is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $9.73B market cap.

Most recent earnings call: Q2 FY26 on Oct 24, 2025.

19 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

Confidence: 0.68

www.drreddys.com/investor

Extracted from Unknown source, 2026-08-30.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 19 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for RDY.

$ curl https://api.spokenalpha.com/v1/companies/RDY

Get an API key API docs

FAQ

Frequently asked about RDY

Where can I find DR REDDYS LABORATORIES LTD's (RDY) earnings call transcripts?

Spoken Alpha indexes RDY's earnings call transcripts at https://spokenalpha.com/companies/RDY. Each call links to attributed speakers and parsed analyst Q&A.

When was DR REDDYS LABORATORIES LTD's most recent earnings call?

DR REDDYS LABORATORIES LTD (RDY) held its most recent earnings call on 2025-10-24, covering fiscal Q2 2026.

What sector is RDY in?

DR REDDYS LABORATORIES LTD (RDY) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

Overview